Results of ENGOT-OV16/NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer VJOncology 2:55 7 years ago 192 Скачать Далее
Dr. Mirza on Final Data of the NSGO-AVANOVA2/ENGOT-OV24 Trial in Ovarian Cancer OncLive 2:18 4 years ago 100 Скачать Далее
Dr. Mirza on the Rationale for the AVANOVA Trial in Recurrent Ovarian Cancer OncLive 2:11 5 years ago 194 Скачать Далее
Trial design of ENGOT-OV16/NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer VJOncology 2:26 7 years ago 75 Скачать Далее
Dr. Mirza on the Evolving Treatment Landscape in Recurrent Ovarian Cancer OncLive 1:30 4 years ago 166 Скачать Далее
NOVA Phase III trial of niraparib in platinum-sensitive ovarian cancer patients VJOncology 2:39 7 years ago 915 Скачать Далее
Combination therapy to treat ovarian cancer: promising results from the ANANOVA trial VJOncology 2:17 6 years ago 71 Скачать Далее
Dr. Mirza Discusses Niraparib Dose Modifications for Ovarian Cancer Patients With Low Body Weight OncLive 2:26 6 years ago 373 Скачать Далее
Dr. Mirza on the ENGOT-OV42-NSGO/AVANOVA-Triplet Trial in Recurrent Ovarian Cancer OncLive 0:49 4 years ago 106 Скачать Далее
Dr. Mirza on Niraparib Plus Bevacizumab Combo in Ovarian Cancer OncLive 1:41 6 years ago 307 Скачать Далее
Dr. Mirza on the Implications of the NSGO-AVANOVA2/ENGOT-OV24 Trial in Ovarian Cancer OncLive 0:56 4 years ago 54 Скачать Далее
Results from the ENGOT-OV16/NOVA trial: efficacy and safety of niraparib in ovarian cancer VJOncology 9:25 7 years ago 1 171 Скачать Далее
Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer OncLive 2:18 5 years ago 296 Скачать Далее
Dr. Ledermann on Phase III ARIEL3 Results in Ovarian Cancer OncLive 1:19 6 years ago 327 Скачать Далее
Niraparib as maintenance for platinum-sensitive ovarian cancer - results from ENGOT-OV16/NOVA trial VJOncology 1:50 7 years ago 400 Скачать Далее
Comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer VJOncology 1:13 7 years ago 2 637 Скачать Далее
